News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Genentech, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Deals
What Happens When a Biotech Gets Bought Out
September 9, 2008
·
1 min read
Biotech Bay
Study Outcome Won’t Sway Genentech, Inc. On Eye Drug
August 28, 2008
·
1 min read
Job Trends
Recruiters Eye Genentech, Inc. Employees
August 18, 2008
·
1 min read
Drug Development
Genentech, Inc. and Biogen Idec, Inc. (Massachusetts) Rituxan May Heal Common Kidney Condition
August 7, 2008
·
1 min read
‘Total’ Sunblock Claims Excessive, Consumer Council Warns
July 15, 2008
·
1 min read
Biotech Bay
Genentech, Inc.'s (JOBS) Avastin Cost Debated Before Wider Use
July 7, 2008
·
1 min read
Biotech Bay
Small is Beautiful -- BioPharm Executive
June 25, 2008
·
2 min read
Policy
Genentech, Inc. Spent $591,000 Lobbying The Federal Government On Biotech Issues In First Quarter
June 2, 2008
·
1 min read
Drug Development
Skin Cancer Breakthrough? Genentech, Inc. and Curis, Inc. Experimental Drug GDC-0449 Shrinks Advanced Skin Cancer
April 15, 2008
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Bay
UK’s National Institute for Clinical Excellence (NICE) Rejects Genentech’s Avastin for Ovarian Cancer
February 1, 2013
·
1 min read
Drug Development
Genentech Says Blood Cancer Drug Met Stage One Goal
January 31, 2013
·
1 min read
Business
Genentech Grabs Afraxis, Inc. Compound Rights for Up to $187.5 Million
January 29, 2013
·
1 min read
BioForest
Invictus Foundation™ Receives Grant From Genentech, a Member of the Roche Group
January 23, 2013
·
2 min read
Drug Development
Genentech Takes Exelixis, Inc. Drug Into Phase III Melanoma Trial
January 17, 2013
·
1 min read
Policy
Genentech’s Cancer-Fighting T-DM1 Leads FDA Class of 2013
December 27, 2012
·
1 min read
Drug Development
Genentech Preps for $100 Million Alzheimer’s Trial
December 14, 2012
·
1 min read
Seattle Genetics, Inc. Highlights Data Presentations From Genentech ADC Collaborator Programs at American Society of Hematology Annual Meeting
December 11, 2012
·
1 min read
Drug Development
Genentech’s Perjeta Extends Life of Breast Cancer Patients by 34 Pct
December 10, 2012
·
7 min read
Biotech Bay
Not in Genentech’s Shadow Anymore, Biogen Idec, Inc. (California) Makes Huge Comeback in Biotech
December 5, 2012
·
1 min read